Refine by
Brain Tissue Articles & Analysis
24 news found
Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...
CD BioSciences now offers a comprehensive portfolio of Nervous System Tissue Microarrays, including Brain Tissue Microarrays and Head & Neck Tissue Microarrays. ...
Through this partnership, we aim to provide researchers with the tools and expertise needed to accelerate their research efforts in developing liver models for drug discovery, accurate cancer models for precision medicine, and exploring the potential of combining light and extrusion bioprinting modalities to advance tissue engineering.” Prof. Shaochen Chen added, ...
ByCELLINK
Here below, discover our top three bestselling kits and find the perfect solution for your sample prep! P000912-LYSK1-A.0 Soft tissue homogenizing CK14 The CK14 kit is the perfect solution for soft tissue homogenization, like brain, liver, kidney, skin, plant leaves, mammalian cells and more. Compatible with Precellys Evolution Touch, ...
The second, REVeRT (REconstitution Via mRNA Trans-splicing) technology platform, allows efficient reconstitution of large genes (>5Kb) in various tissues such as retina, brain, heart, liver, and skeletal muscle. The third, AAV Transactivation is a CRISPR-Cas–based AAV gene therapy platform that enables to regulate one or multiple genes in vivo. ...
Last week Tobias Granberg, a Swedish researcher from Karolinska Institutet, appeared on TV4 Nyhetsmorgon together with his colleague Miia Kivipelto to share the results of their research where they investigated the influence of COVID-19 on the brain using, among others, Cercare Perfusion. The research shows changes in brain tissue ...
The drug improves stroke treatment rates while expanding treatment coverage, providing neuroprotection, and reducing irreversible damage to the brain ...
ClearLight’s mission has been to empower researchers to See More Biology™ within the tissue microenvironment. We have been developing technologies to improve diagnostic, prognostic, and predictive treatment of disease so we can all live healthier lives. The company has pioneered 3D Immunohistochemistry and developed many improvements to the CLARITY protocol, ...
HyStem is a patented hydrogel which mimics naturally occurring extracellular matrix, the structural network of molecules surrounding cells in organs and tissues and essential to cellular function and tissue structure. HyStem biomaterial has been shown to support cellular attachment and survival as well as compatibility with a wide variety of cells and ...
It is estimated that more than 240,000 cases of brain and nervous system tumors are diagnosed each year around the world. ...
Although such a problem is less common with living transplants, brain-dead transplants are prone to tissue damage and inflammation due to free radicals due to the time the organs are transported. ...
The paper, “A gut-derived metabolite alters brain activity and anxiety behavior in mice,” offers new mechanistic insight into how the gut microbiome can influence complex behaviors via the gut-brain axis. ...
As previously reported, NeuroOne is also advancing a pipeline of therapeutic electrode technologies for brain tissue ablation, chronic stimulation use for DBS (deep brain stimulation) and spinal cord stimulation for chronic back pain. ...
“There are several advantages of this therapy that benefit the patient, including no additional trips to the hospital for radiation treatments, protection of healthy scalp and brain tissue, and lower overall level of radiation exposure,” Dr. ...
In as little as 30 seconds after a Swoop scan, advanced artificial intelligence applications analyze and return annotated, segmented brain images, providing clinicians with quantitative markers for decision support and immediate feedback for diagnostic insight. ...
If at least 1 of 5 demonstrates the presence of LB-100 in tumor tissue, 3 additional subjects will be enrolled. If at least 2 of the 8 patients demonstrate LB-100 in tumor tissue, the study will be considered significant providing further support for studying if the addition of LB-100 to standard treatment regimens for malignant brain tumors ...
Now, the Montreal-based company that Petrecca helped found is poised to solve the problem of residual brain cancer. Reveal Surgical is taking aim at glioblastomas, the most common and fatal type of malignant brain tumour. ...
Outcomes will include the use of the brain data to control digital devices and achieve improvements in functional independence. ...
A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors while protecting healthy ...
A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors while protecting healthy ...